191 related articles for article (PubMed ID: 31992826)
1. VGLL3 is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in stomach adenocarcinoma.
Zhang L; Li L; Mao Y; Hua D
Sci Rep; 2020 Jan; 10(1):1355. PubMed ID: 31992826
[TBL] [Abstract][Full Text] [Related]
2. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
3. Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma.
Guo L; Liu D
Eur J Med Res; 2022 Aug; 27(1):164. PubMed ID: 36045400
[TBL] [Abstract][Full Text] [Related]
4. LncRNA DIRC1 is a novel prognostic biomarker and correlated with immune infiltrates in stomach adenocarcinoma.
Lin Y; Zhang Z; Li Y; Chen Y; Su M; Zhao W
Medicine (Baltimore); 2022 Nov; 101(46):e31839. PubMed ID: 36401393
[TBL] [Abstract][Full Text] [Related]
5. WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma.
Yuan Q; Zhou Q; Ren J; Wang G; Yin C; Shang D; Xia S
Cancer Med; 2021 Jun; 10(12):4004-4016. PubMed ID: 33982398
[TBL] [Abstract][Full Text] [Related]
6. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
[TBL] [Abstract][Full Text] [Related]
7. High Expression of the Component 3a Receptor 1 (C3AR1) Gene in Stomach Adenocarcinomas Infers a Poor Prognosis and High Immune-Infiltration Levels.
Yang H; Li L; Liu X; Zhao Y
Med Sci Monit; 2021 Feb; 27():e927977. PubMed ID: 33539329
[TBL] [Abstract][Full Text] [Related]
8. Identification of potential targets of triptolide in regulating the tumor microenvironment of stomach adenocarcinoma patients using bioinformatics.
Qiu H; Zhang X; Yu H; Gao R; Shi J; Shen T
Bioengineered; 2021 Dec; 12(1):4304-4319. PubMed ID: 34348580
[TBL] [Abstract][Full Text] [Related]
9. High Endothelin Receptor Type A Expression as an Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Stomach Adenocarcinoma.
Yan Y; Nie K; Zheng J; Jiang X; Huang Y; Zheng Z; Wen Y; Li P
Cancer Manag Res; 2021; 13():5013-5026. PubMed ID: 34234547
[TBL] [Abstract][Full Text] [Related]
10. An abnormally high expression of ISL-1 represents a potential prognostic factor in gastric cancer.
Guo C; Wang W; Shi Q; Chen P; Zhou C
Hum Pathol; 2015 Sep; 46(9):1282-9. PubMed ID: 26142548
[TBL] [Abstract][Full Text] [Related]
11. Cytokine-Like Protein 1 (CYTL1) as a Key Target of M-Stage Immune Infiltration in Stomach Adenocarcinoma.
Zhou F; Lin Q; Zheng Z
Biomed Res Int; 2023; 2023():2926218. PubMed ID: 36825034
[TBL] [Abstract][Full Text] [Related]
12. Increased ANXA5 expression in stomach adenocarcinoma infers a poor prognosis and high level of immune infiltration.
Su Z; Shu K; Li G
Cancer Biomark; 2022; 35(2):155-165. PubMed ID: 35912732
[TBL] [Abstract][Full Text] [Related]
13. A novel microRNA signature predicts survival in stomach adenocarcinoma.
Ding B; Gao X; Li H; Liu L; Hao X
Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma.
Wu M; Xia Y; Wang Y; Fan F; Li X; Song J; Ding J
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33112406
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Bioinformatic Analysis of NOTCH Pathway Involvement in Stomach Adenocarcinoma.
Xue D; Li D; Dou C; Li J
Dis Markers; 2021; 2021():4739868. PubMed ID: 34925644
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value and Immune Infiltrates of ABCA8 and FABP4 in Stomach Adenocarcinoma.
Guo Y; Wang ZW; Su WH; Chen J; Wang YL
Biomed Res Int; 2020; 2020():4145164. PubMed ID: 32685482
[TBL] [Abstract][Full Text] [Related]
17. Vestigial like family member 3 is a novel prognostic biomarker for gastric cancer.
Zhang LH; Wang Z; Li LH; Liu YK; Jin LF; Qi XW; Zhang C; Wang T; Hua D
World J Clin Cases; 2019 Aug; 7(15):1954-1963. PubMed ID: 31423427
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of expression signature and immune microenvironment signature of biomarker Endothelin Receptor Type A in stomach adenocarcinoma.
Wang Z; Wang K; Yu X; Chen M; Du Y
J Cancer; 2022; 13(7):2086-2104. PubMed ID: 35517422
[No Abstract] [Full Text] [Related]
19. ASF1B acted as a prognostic biomarker for stomach adenocarcinoma.
Zhao C; Zhou J; Xing J; Yin Q
Medicine (Baltimore); 2023 Dec; 102(48):e35408. PubMed ID: 38050219
[TBL] [Abstract][Full Text] [Related]
20. CFP is a prognostic biomarker and correlated with immune infiltrates in Gastric Cancer and Lung Cancer.
Cui G; Geng L; Zhu L; Lin Z; Liu X; Miao Z; Jiang J; Feng X; Wei F
J Cancer; 2021; 12(11):3378-3390. PubMed ID: 33976747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
